Valneva sees lower 2026 sales as third-party revenue winds down
Valneva (VALN) expects total revenue of €155M–€170M in 2026, including product sales of €145M–€160M. The lower...
Tag: VALN
Valneva chikungunya shot no longer recommended for older adults in U.K.
Valneva (VALN) announced on Friday that the U.K. regulators have updated recommendations for the use of its chikungunya...
Valneva ends chikungunya vaccine deal with India’s Serum Institute
Valneva (VALN) and the world’s largest vaccine maker, Serum Institute of India, announced on Wednesday that they have...
New York reports first locally acquired chikungunya case in U.S. since 2019
A person in Nassau County, New York, has tested positive for the chikungunya virus, a case state health officials confirmed...
Valneva lowers 2025 financial outlook due to loss of Ixchiq vaccine marketing
Valneva SE (NASDAQ:VALN) is cutting its 2025 full-year sales and revenue guidance as a result of the US FDA's August...
Biggest stock movers Monday: NIO, VALN, and more
Stock futures edged lower Monday morning as Wall Street kicked off the final trading week of August with focus on Nvidia’s...
Valneva suspended from marketing chikungunya shot in U.S. over safety concerns
The U.S. Food and Drug Administration (FDA) late Friday announced that it has suspended the marketing application granted...
Valneva reports 1H results; reaffirms FY outlook
Valneva press release (NASDAQ:VALN): 1H net loss of €20.8 million compared to a net profit of €34.0 million in the...
FDA lifts pause on Valneva’s chikungunya vaccine in elderly
designer491/iStock via Getty ImagesValneva SE (NASDAQ:VALN) said on Thursday that the FDA has lifted its pause on the use of...
CDC mulls travel notice for China amid rise in chikungunya cases
The Centers for Disease Control and Prevention (CDC) in the United States weighs releasing a travel advisory for China due...